Tag: suboxone

Not available?

~ Jason Schwartz ~ 12 Comments

Another study finds no benefit from cognitive behavioral therapy and contingency management with opiate replacement treatment. [CORRECTED: See below] Background and aims The Controlled Substances Act requires physicians in the United States to provide or refer to behavioral treatment when treating opioid-dependent individuals with buprenorphine; however no research has examined the combination of buprenorphine with … Continue reading Not available?

2012′s most popular posts #8 – Another Reaction to Hazelden’s Adoption of Suboxone

~ Jason Schwartz ~ 3 Comments

Mark Willenbring, a former Director of the Treatment and Recovery Research Division of the National Institute on Alcohol Abuse and Alcoholism/National Institutes of Health weighs in on Hazelden's embrace of Suboxone Hazelden's new approach is a seismic shift that is likely to move the entire industry in this direction. I told Marv that it was like … Continue reading 2012′s most popular posts #8 – Another Reaction to Hazelden’s Adoption of Suboxone

Lines are being drawn

~ Jason Schwartz ~ 4 Comments

  A major treatment provider, Caron, weighs in on Hazelden's adoption of buprenorphine maintenance treatment:   We use buprenorphine (Suboxone) to assist with the detoxification process from opioids and the length of time can vary depending on the patient’s progress and additional medical issues, such as chronic pain. However, unlike Hazelden’s goal as stated in … Continue reading Lines are being drawn

Suboxone Strategy: Protecting Patients Or Profits?

~ Jason Schwartz ~ 1 Comment

I'm a little late on posting this one, but it still seems worth sharing. Reckitt Benckiser has decided to pull Suboxone tablets from the market. Why? It's an evidence-based decision and an expression of their desire to be a good corporate citizen and their concern for children. Late last month, Reckitt Benckiser created a stir … Continue reading Suboxone Strategy: Protecting Patients Or Profits?

Another Reaction to Hazelden’s Adoption of Suboxone

~ Jason Schwartz ~ 16 Comments

Mark Willenbring, a former Director of the Treatment and Recovery Research Division of the National Institute on Alcohol Abuse and Alcoholism/National Institutes of Health weighs in on Hazelden's embrace of Suboxone Hazelden's new approach is a seismic shift that is likely to move the entire industry in this direction. I told Marv that it was like … Continue reading Another Reaction to Hazelden’s Adoption of Suboxone

Road traffic crashes and prescribed methadone and buprenorphine

~ Jason Schwartz ~ 1 Comment

Last year, a study questioned whether buprenorphine patients should be allowed to drive because 60% tested positive for other drugs. Now, another study reaches similar findings: Background Opioids have been shown to impair psychomotor and cognitive functioning in healthy volunteers with no history of opioid abuse. Few or no significant effects have been found in opioid-dependant … Continue reading Road traffic crashes and prescribed methadone and buprenorphine

Top Posts of 2011 #1 – The Suboxone “Solution”

~ Jason Schwartz ~ 3 Comments

The Fix has a provocative article on the growing use of buprenorphine maintenance. Over the last several years we've watched long-term maintenance become the norm and it has been a growing concern at Dawn Farm, particularly as we've had growing numbers of people misusing the drug and others seeking help getting detoxed from buprenorphine. She … Continue reading Top Posts of 2011 #1 – The Suboxone “Solution”